- Previous Close
756.85 - Open
754.95 - Bid 735.55 x --
- Ask 736.25 x --
- Day's Range
728.15 - 755.00 - 52 Week Range
420.00 - 885.00 - Volume
456,936 - Avg. Volume
616,491 - Market Cap (intraday)
116.454B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
66.20 - EPS (TTM)
11.13 - Earnings Date Oct 22, 2024
- Forward Dividend & Yield 5.00 (0.66%)
- Ex-Dividend Date Aug 2, 2024
- 1y Target Est
818.00
Jubilant Ingrevia Limited engages in the life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol. The company provides piperidines, metal complexes, choline salts, vitamin B3, Vitamin B4, picolinates, riboflavin phosphate sodium, nutritional premixes, antioxidants, straight ingredients, acetic anhydride, acetic acid, ethyl acetate, propionic anhydride, formaldehyde, bio acetic acid-food grade, acetaldehyde, and ethanol, as well as cyano, acetyl, amino, halo, alkyl, and aldehyde pyridines. In addition, it offers route design, process development, process optimization, and scale-up and commercial manufacturing of intermediates. Further, the company provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and industrial customers. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
jubilantingrevia.com2,283
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: JUBLINGREA.NS
View MorePerformance Overview: JUBLINGREA.NS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: JUBLINGREA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: JUBLINGREA.NS
View MoreValuation Measures
Market Cap
119.57B
Enterprise Value
125.64B
Trailing P/E
68.25
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.95
Price/Book (mrq)
4.25
Enterprise Value/Revenue
3.09
Enterprise Value/EBITDA
27.40
Financial Highlights
Profitability and Income Statement
Profit Margin
4.27%
Return on Assets (ttm)
-1.99%
Return on Equity (ttm)
6.37%
Revenue (ttm)
41.1B
Net Income Avi to Common (ttm)
1.76B
Diluted EPS (ttm)
11.13
Balance Sheet and Cash Flow
Total Cash (mrq)
626.2M
Total Debt/Equity (mrq)
25.56%
Levered Free Cash Flow (ttm)
-1.49B